Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Pal

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Drugs & Aging|October 23, 2025
Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way ForwardJessie Nguyen, Nicolò Matteo Luca Battisti, Danielle Ní Chróinín, et al.
Pathology|November 19, 2025
Histopathological associations, molecular findings and clinical outcomes of patients with non-small cell lung carcinoma with MET alterations: a 3-year retrospective Australian case seriesJing Jing Li, Jawad Saab, Victoria Bray, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
A Wolf in Sheep's Clothing: Systemic Immune Activation Post ImmunotherapyCrescens Tiu, Rajiv Shinde, Abhijit Pal, et al.
BMC Palliative Care|May 17, 2024
Co-designing strategies to improve advance care planning among people from culturally and linguistically diverse backgrounds with cancer: iCanCarePlan study protocolAshfaq Chauhan, Upma Chitkara, Ramya Walsan, et al.
Cancers|May 4, 2026
Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical TrialsJessie Nguyen, Udit Nindra, Joanne Tang, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
JNCI Cancer Spectrum|November 10, 2025
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLERUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
JCO Oncology Practice|November 3, 2025
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort StudyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
Internal Medicine Journal|September 15, 2023
Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancerUdit Nindra, Abhijit Pal, Victoria Bray, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Drugs & Aging|October 23, 2025
Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way ForwardJessie Nguyen, Nicolò Matteo Luca Battisti, Danielle Ní Chróinín, et al.
Pathology|November 19, 2025
Histopathological associations, molecular findings and clinical outcomes of patients with non-small cell lung carcinoma with MET alterations: a 3-year retrospective Australian case seriesJing Jing Li, Jawad Saab, Victoria Bray, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
A Wolf in Sheep's Clothing: Systemic Immune Activation Post ImmunotherapyCrescens Tiu, Rajiv Shinde, Abhijit Pal, et al.
BMC Palliative Care|May 17, 2024
Co-designing strategies to improve advance care planning among people from culturally and linguistically diverse backgrounds with cancer: iCanCarePlan study protocolAshfaq Chauhan, Upma Chitkara, Ramya Walsan, et al.
Cancers|May 4, 2026
Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical TrialsJessie Nguyen, Udit Nindra, Joanne Tang, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
JNCI Cancer Spectrum|November 10, 2025
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLERUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
JCO Oncology Practice|November 3, 2025
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort StudyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
Internal Medicine Journal|September 15, 2023
Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancerUdit Nindra, Abhijit Pal, Victoria Bray, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Pageof 5